Your browser doesn't support javascript.
loading
YY1 targets tubulin polymerisation-promoting protein to inhibit migration, invasion and angiogenesis in pancreatic cancer via p38/MAPK and PI3K/AKT pathways.
Chen, Qun; Yang, Chuang; Chen, Lei; Zhang, Jing-Jing; Ge, Wan-Li; Yuan, Hao; Meng, Ling-Dong; Huang, Xu-Min; Shen, Peng; Miao, Yi; Jiang, Kui-Rong.
Afiliação
  • Chen Q; Pancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Yang C; Pancreas Institute, Nanjing Medical University, Nanjing, China.
  • Chen L; Pancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Zhang JJ; Pancreas Institute, Nanjing Medical University, Nanjing, China.
  • Ge WL; Pancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Yuan H; Pancreas Institute, Nanjing Medical University, Nanjing, China.
  • Meng LD; Pancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Huang XM; Pancreas Institute, Nanjing Medical University, Nanjing, China.
  • Shen P; Pancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Miao Y; Pancreas Institute, Nanjing Medical University, Nanjing, China.
  • Jiang KR; Pancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Br J Cancer ; 121(11): 912-921, 2019 11.
Article em En | MEDLINE | ID: mdl-31631174
ABSTRACT

BACKGROUND:

Pancreatic cancer (PDAC) is a highly invasive cancer with poor prognosis. Recent research has found that the transcription factor Yin Yang 1 (YY1) plays an inhibitory role in the development of pancreatic cancer. It has been reported that tubulin polymerisation-promoting protein (TPPP) plays an indispensable role in a variety of tumours, but its expression and role in pancreatic cancer have not yet been elucidated.

METHODS:

In this study, we performed ChIP-sequencing and found that YY1 directly binds to the promoter region of TPPP. The expression of TPPP in pancreatic cancer was detected by western blotting and immunohistochemistry. Four-week-old male BALB/c-nude mice were used to assess the effect of TPPP on pancreatic cancer.

RESULTS:

Immunohistochemistry revealed that TPPP was expressed at low levels in pancreatic cancer tissues, and was associated with blood vessel invasion. The results from vivo experiments have showed that TPPP could enhance the migration and invasion of pancreatic cancer. Further experiments showed that YY1 could inhibit the migration, invasion and angiogenesis of pancreatic cancer cells by downregulating TPPP via p38/MAPK and PI3K/AKT pathways.

CONCLUSION:

Our study demonstrates that TPPP may act as a promoter and may serve as a novel target for the treatment of pancreatic cancer.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Movimento Celular / Fosfatidilinositol 3-Quinases / Proteínas Quinases p38 Ativadas por Mitógeno / Proteínas Proto-Oncogênicas c-akt / Fator de Transcrição YY1 / Neovascularização Patológica / Proteínas do Tecido Nervoso Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Movimento Celular / Fosfatidilinositol 3-Quinases / Proteínas Quinases p38 Ativadas por Mitógeno / Proteínas Proto-Oncogênicas c-akt / Fator de Transcrição YY1 / Neovascularização Patológica / Proteínas do Tecido Nervoso Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article